VIVEbiotech provides process development, manufacturing and analytical testing for leading biopharmaceutical companies engaged in gene therapy and cell therapy projects. With a specific focus on lenti...
Read moreHan demostrado en pacientes afectados por el subtipo A de la anemia de Fanconi (causado por mutaciones en el gen FANCA) que incluso en ausencia de acondicionamiento con quimioterapia, la autotransfusi...
Read moreA group of purification specialists in a small town in western Slovenia develops innovative technologies that separate right from wrong fast and efficiently – making sure patients worldwide receive ...
Read moreLos resultados muestran que la terapia ha corregido un mecanismo de comunicación neuronal alterado en la enfermedad y ha mejorado la capacidad de movimiento y de aprendizaje de los ratones con SPG52
Read moreSB-007 is the only IND-cleared, clinical-stage therapeutic addressing the root cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations
Read moreThe pharmaceutical industry in 2025 stands at a point of major change. AI and gene editing are making drug development faster. Cell therapies are becoming standard treatments. Digital tools are making...
Read moreThe Sartorius team in Slovenia developed a fully automated system for bacterial cell lysis in plasmid DNA production. Read how they are part of the solution in producing new therapies by addressing a ...
Read moreEstas tecnologÃas permitirán mejorar cultivos como el tomate valenciano y los cÃtricos, para hacerlos más resistentes a la sequÃa y otras condiciones adversas
Read moreDSMB confirms favorable safety profile of SPVN06 across all three doses in patients with severe advanced rod-cone dystrophy (RCD)
Read moreUn equipo de la UCO aplica la técnica de edición genómica ganadora del Nobel de QuÃmica en 2020 para desentrañar las funciones de dos genes implicados en el metabolismo de la judÃa y que no habÃ...
Read moreBiotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non-specific treatments to those tailored to the unique characteristics of each patient. ...
Read moreUsing gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering them or producing them in excess, thereby allowing observation of their true function.
Read more